Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "GPCRs and other protein targets" refers collectively to G protein-coupled receptors and additional categories of druggable proteins, such as ion channels, kinases, nuclear hormone receptors, enzymes, and transporters. GPCRs themselves form the largest and arguably most important superfamily of membrane receptors in humans, with more than 800 members regulating diverse physiological and pathological processes. They are prime therapeutic targets, involved in diseases such as hypertension, pain, diabetes, obesity, Alzheimer's disease, and others. However, the phrase is too broad and nonspecific to uniquely define a single molecular entity suitable as a database target entry. It encompasses numerous gene and protein families with distinct structural and functional features, ligand types, and clinical importance[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPCRs and other protein targets.